EU and UK merger control in the pharmaceutical sector


Reproduced from Practical Law with the permission of the publishers. For further information visit

Partner Stephen Smith and associate Edwin Bond provide a general overview of the EU and UK merger control regimes and a discussion of issues that are of particular relevance to the pharma sector, including market definition, price and innovation effects of horizontal mergers, and remedies.

Read the full PDF article here.

Note: In January 2022 Stephen, Edwin and Isobel updated this overview to reflect changes in the law. You can read the new version here.

Stephen Smith


Edwin Bond


Related Articles